<?xml version="1.0" encoding="iso-8859-1"?>
<rss version="2.0"><channel><title>TGaceAllStories</title><link>http://example.com/interleaved_feed.xml</link><description>This is a randomly ordered feed of the most recent entries from TGaceAllStories, skipping any feeds with errors.</description><lastBuildDate>Mon, 29 Sep 2025 06:35:38 GMT</lastBuildDate><generator>PyRSS2Gen-1.1.0</generator><docs>http://blogs.law.harvard.edu/tech/rss</docs><item><title>Morgan Stanley expects Novo Nordisk Alzheimer trial to fail as it slashes rating</title><link>https://www.marketwatch.com/story/morgan-stanley-expects-novo-nordisk-alzheimer-trial-to-fail-as-it-slashes-rating-98a9eeee?mod=mw_rss_topstories</link><image_url>https://images.mktw.net/im-86179513</image_url><description>Morgan Stanley analysts say a trial to test whether Novo Nordisk’s blockbuster weight-loss drug also will work against Alzheimer’s is likely to fail, ...</description><pubDate>Mon, 29 Sep 2025 10:36:00 GMT</pubDate></item><item><title>How the Trump administration is boosting stock buybacks</title><link>https://www.marketwatch.com/story/the-trump-effect-on-share-buybacks-theres-more-of-them-a8d93235?mod=mw_rss_topstories</link><image_url>https://images.mktw.net/im-79494160</image_url><description>Gavekal Research predicts more stock repurchases are coming, representing an additional tailwind for the current bull market.</description><pubDate>Mon, 29 Sep 2025 10:22:00 GMT</pubDate></item><item><title>Months after cancer drug trial, Merus agrees to be bought at 41% premium</title><link>https://www.marketwatch.com/story/months-after-cancer-drug-trial-merus-agrees-to-be-bought-at-41-premium-d7e87829?mod=mw_rss_topstories</link><image_url>https://images.mktw.net/im-34081553</image_url><description>Merus agreed to be bought for a 41% premium, months after a positive trial of a cancer drug.</description><pubDate>Mon, 29 Sep 2025 10:34:00 GMT</pubDate></item><item><title>‘He’s the breadwinner’: Does my husband take Social Security at 66 — or wait to get $800 extra at 70?</title><link>https://www.marketwatch.com/story/hes-the-breadwinner-does-my-husband-take-social-security-at-66-or-wait-to-get-800-extra-at-70-33b0ed85?mod=mw_rss_topstories</link><image_url>https://images.mktw.net/im-40443151</image_url><description>“My husband jokes that he will never be able to retire because we do not own a home.”</description><pubDate>Mon, 29 Sep 2025 10:25:00 GMT</pubDate></item><item><title>‘I thought she was honest’: My ex-wife hid stocks during our divorce. Can I sue her?</title><link>https://www.marketwatch.com/story/i-thought-she-was-honest-my-ex-wife-hid-her-stocks-during-our-divorce-can-i-sue-her-e75cab43?mod=mw_rss_topstories</link><image_url>https://images.mktw.net/im-37270843</image_url><description>“I have contacted her about it, but she refuses to answer my calls.”</description><pubDate>Mon, 29 Sep 2025 11:23:00 GMT</pubDate></item><item><title>Morgan Stanley downgrades Wells Fargo, sees limited upside ahead</title><link>https://www.cnbc.com/2025/09/29/morgan-stanley-downgrades-wells-fargo-sees-limited-upside-ahead.html</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture1.png</image_url><description>Don't expect much more upside for Wells Fargo, according to Morgan Stanley.</description><pubDate>Mon, 29 Sep 2025 11:27:21 GMT</pubDate></item><item><title>BYD bids Warren Buffett's Berkshire an unfazed farewell: Selling is 'normal'</title><link>https://www.cnbc.com/2025/09/27/byd-warren-buffett-berkshire-hathaway.html</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture5.png</image_url><description>As it confirmed Berkshire has sold the last of its shares, the Chinese EV maker thanked Buffett and Munger for their 17-year investment.</description><pubDate>Sun, 28 Sep 2025 03:40:32 GMT</pubDate></item><item><title>Want to beat the market for the long term? JPMorgan says bet on termites</title><link>https://www.cnbc.com/2025/09/28/want-to-beat-the-market-for-the-long-term-jpmorgan-says-bet-on-termites.html</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture6.png</image_url><description>Rollins could gain ground as the firm deepens its push into the "resilient," multibillion-dollar pest control market in the U.S. and abroad, per J.P. ...</description><pubDate>Sun, 28 Sep 2025 12:43:25 GMT</pubDate></item><item><title>Top Wall Street analysts favor these 3 stocks for their robust growth outlook</title><link>https://www.cnbc.com/2025/09/28/top-wall-street-analysts-favor-these-3-stocks-for-robust-growth.html</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture9.png</image_url><description>TipRanks' ranking service highlights three stocks, including Nvidia and CrowdStrike, that are favored by Wall Street.</description><pubDate>Sun, 28 Sep 2025 12:48:35 GMT</pubDate></item><item><title>Trump is wielding the power of the state to back critical mineral companies. These are the possible next targets</title><link>https://www.cnbc.com/2025/09/28/mp-materials-lithium-americas-lac-rare-earth-trump-stake.html</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture8.png</image_url><description>The Pentagon deal with MP Materials could provide a blueprint to protect U.S miners against market manipulation by China, executives and analysts say.</description><pubDate>Sun, 28 Sep 2025 12:45:51 GMT</pubDate></item><item><title>Datavault AI (DVLT) Rockets on $150 Million Scilex Cash Infusion: The Deal That’s Got Traders Buzzing</title><link>https://ragingbull.com/editorial/datavault-ai-dvlt-rockets-on-150-million-scilex-cash-infusion-the-deal-thats-got-traders-buzzing/</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture5.png</image_url><description>Listen up, folks—markets don’t hand out fireworks like this every day, but when they do, you better pay attention. As of this writing, early in the tr...</description><pubDate>Fri, 26 Sep 2025 14:39:33 GMT</pubDate></item><item><title>bioAffinity Technologies Stock Explodes 80%+ in Pre-Market on Fresh Lung Cancer Detection Wins</title><link>https://ragingbull.com/editorial/bioaffinity-technologies-stock-explodes-80-in-pre-market-on-fresh-lung-cancer-detection-wins/</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture3.png</image_url><description>Listen up, folks—markets are a wild ride, and right now, one tiny biotech name is stealing the show with a pre-market pop that could make your head sp...</description><pubDate>Fri, 26 Sep 2025 14:40:57 GMT</pubDate></item><item><title>MRM Stock Explodes on Game-Changing Partnership with Sam Altman’s World: Inside the Pre-Market Surge</title><link>https://ragingbull.com/editorial/mrm-stock-explodes-on-game-changing-partnership-with-sam-altmans-world-inside-the-pre-market-surge/</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture6.png</image_url><description>Folks, if you’re scanning the markets this morning, you’ve got to be seeing this one lighting up the screens like a Fourth of July fireworks show. MED...</description><pubDate>Fri, 26 Sep 2025 14:37:14 GMT</pubDate></item><item><title>Safe &amp; Green Holdings (SGBX) Surges on Long-Awaited Litigation Settlement – What’s Driving the Buzz in Modular Construction?</title><link>https://ragingbull.com/editorial/safe-green-holdings-sgbx-surges-on-long-awaited-litigation-settlement-whats-driving-the-buzz-in-modular-construction/</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture3.png</image_url><description>Listen up, folks – if you’re glued to the markets this morning, you’ve probably spotted Safe &amp; Green Holdings Corp. (NASDAQ: SGBX) lighting up the boa...</description><pubDate>Thu, 25 Sep 2025 14:47:16 GMT</pubDate></item><item><title>Plus Therapeutics (PSTV) Rockets 40% on Major Insurance Win for Cancer Detection Tool – Here’s Why Traders Are Buzzing</title><link>https://ragingbull.com/editorial/plus-therapeutics-pstv-rockets-40-on-major-insurance-win-for-cancer-detection-tool-heres-why-traders-are-buzzing/</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture6.png</image_url><description>Listen up, folks – if you’re glued to the market this morning, you’ve probably spotted that wild mover lighting up your screen: Plus Therapeutics, tic...</description><pubDate>Thu, 25 Sep 2025 14:48:19 GMT</pubDate></item></channel></rss>